Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,715 shares at $36.57 ($63K) on 2015-02-02, disclosed to the SEC on 2015-02-03.
Scheduled sale ($63k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.57 | 1,215 | $44K | 70.5% |
| 2 | $37.21 | 500 | $19K | 29.5% |
| Total | $36.76 avg | 1,715 | $63K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |